- Home
- CR vs BRKR Comparison
CR vs BRKR Comparison
Compare CR & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CR | BRKR |
|---|---|---|
| Founded | 1855 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 7.3B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | CR | BRKR |
|---|---|---|
| Price | $193.86 | $52.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 13 |
| Target Price | ★ $223.20 | $49.69 |
| AVG Volume (30 Days) | 285.6K | ★ 2.0M |
| Earning Date | 01-26-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.47% | 0.38% |
| EPS Growth | ★ 37.96 | N/A |
| EPS | ★ 6.25 | N/A |
| Revenue | $2,268,100,000.00 | ★ $3,438,900,000.00 |
| Revenue This Year | $10.83 | $3.55 |
| Revenue Next Year | $14.14 | $1.49 |
| P/E Ratio | $31.42 | ★ N/A |
| Revenue Growth | ★ 19.64 | 6.10 |
| 52 Week Low | $127.04 | $28.53 |
| 52 Week High | $203.89 | $64.64 |
Technical Indicators
Market Signals| Indicator | CR | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 59.69 | 69.08 |
| Support Level | $183.16 | $46.85 |
| Resistance Level | $188.96 | $53.47 |
| Average True Range (ATR) | 3.75 | 1.56 |
| MACD | 0.70 | 0.40 |
| Stochastic Oscillator | 71.93 | 86.26 |
Price Performance
Historical ComparisonAbout CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.